Skip to main content

Table 1 NRXN1 variants identified in this study

From: Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia

Chr

Position dbSNP ID

Ref

Val

Amino acid variant

Our cohort

iJGVDa

HGVDa

gnomADa

ClinVar

Tools for predicting the deleteriousness of missense variants

NP_004792

MAF

MAF

MAF

MAF

PolyPhen-2

MutationTaster

REVELb

CADDc

NP_620072

2

50091401

C

T

V1214I

1 SCZ

6/7100

4/2420

12/251454

–

0.245

29

0.242

22.1

rs752722196

V179I

8.9 × 10− 4

8.4 × 10 − 4

1.7 × 10 − 3

4.8 × 10 − 5

Benign

Polymorphism

2

50091446

C

T

A1199T

2 ASD/1 SCZ

17/7086

10/2420

107/282828

Likely benign

0.087

58

0.233

16.98

rs201336161

A164T

2.7 × 10 − 3

2.4 × 10 − 3

4.1 × 10 − 3

3.8 × 10 − 4

Benign

Polymorphism

2

50236845

C

T

V1164I

1 ASD

2/7104

1/2054

12/282134

–

0.460

29

0.15

14.39

 

rs201881725

  

V129I

8.9 × 10 − 4

2.8 × 10 − 4

4.9 × 10 − 4

4.3 × 10 − 5

 

Probably damaging

Polymorphism

  

2

50497646

G

A

R856W

1 SCZ

–

–

–

Uncertain

1.0

101

0.706

27.8

rs796052777

–

8.9 × 10 − 4

Significance

Probably damaging

Disease causing

2

50531259

T

C

D772G

1 ASD

–

–

1/248460

–

1.0

94

0.761

29.6

rs1457374261

–

8.9 × 10 − 4

4.0 × 10 − 6

Probably damaging

Disease causing

2

50531364

G

A

T737M

1 ASD/1 SCZ

–

–

2/247276

Uncertain

1.0

81

0.686

28.4

rs199970666

–

1.8 × 10 − 3

  

8.1 × 10 − 6

Significance

Probably damaging

Disease causing

  1. Genomic position based on NCBI build GRCh38.p12 (Ensembl Transcript IDs ENST00000406316.6 and ENST00000342183.9). The amino acid position is based on NCBI reference sequences NP_004792 and NP_620072, respectively
  2. Chr chromosome, dbSNP dbSNP build 151, Ref reference, Val variant, MAF minor allele frequency, SCZ schizophrenia, ASD autism spectrum disorders, iJGVD integrative Japanese Genome Variation Database, HGVD Human Genetic Variation Database, gnomAD Genome Aggregation Database, ClinVar NCBI ClinVar, PolyPhen-2 polymorphism phenotyping v.2, REVEL Rare Exome Variant Ensemble Learner, CADD Combined Annotation–Dependent Depletion v1.4
  3. For details of each database, see Supplemental methods. None of the SNVs detected in our study were registered in the DECIPHER database
  4. aMinor allele count/total allele count
  5. bThe REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing
  6. cReference genome SNVs at the 10th-% of CADD scores are assigned to 10, top 1 to 20% and top 0.1 to 30%